AMR Conventions Research
Naperville, Illinois, United States
Research institute in Warrenville, Illinois
4300 Weaver Pkwy Suite 100-A, Warrenville, IL 60555
About AMR Conventions Research
"You can become a crucial part of the future of medicine and scientific advancements. With over 15 years of delivering world-class phase II and phase III clinical research for pharmaceutical companies; AMR Conventions Research has been raising the bar on industry standards for more than a decade; all while setting its sights on the future of how we can help improve and extend patients’ lives."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sunovion
2
Supernus Pharmaceuticals, Inc.
2
H. Lundbeck A/S
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Shire
1
Clinical Trials at AMR Conventions Research
During the past decade, AMR Conventions Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
2012-04-17
2014-01-22
Completed
464
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)
2015-03-01
2019-11-01
Completed
297
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)
2016-05-18
2022-01-21
Completed
683
Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment
2018-07-31
2020-01-22
Terminated
186
A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
2019-10-17
2021-06-27
Completed
332
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
2021-12-21
2025-05-31
Recruiting
522
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).
2022-03-17
2029-05-31
Enrolling by invitation
355
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AMR Conventions Research" #1 sponsor was "Sunovion" with 2 trials, followed by "Supernus Pharmaceuticals, Inc." with 2 trials
sponsored, "H. Lundbeck A/S" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Shire"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AMR Conventions Research"
#1 collaborator was "Takeda" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at AMR Conventions Research
According to Clinical.Site data, the most researched conditions in "AMR Conventions Research" are
"Depressive Episodes, Bipolar I Depression" (2 trials), "Attention Deficit Hyperactivity Disorder" (1 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials), "Attention-deficit/Hyperactivity Disorder" (1 trials) and "Borderline Personality Disorder" (1 trials). Many other conditions were trialed in "AMR Conventions Research" in a lesser frequency.
Clinical Trials Intervention Types at AMR Conventions Research
Most popular intervention types in "AMR Conventions Research" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "SPN-810" (2 trials), "Brexpiprazole" (1 trials), "Fluoxetine 20mg/day" (1 trials) and "Lisdexamfetamine dimesylate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AMR Conventions Research
The vast majority of trials in "AMR Conventions Research" are
7 trials for "All" genders.
Clinical Trials Status at AMR Conventions Research
Currently, there are NaN active trials in "AMR Conventions Research".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 4 completed trials in AMR Conventions Research,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in AMR Conventions Research, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".